axicabtagene ciloleucel
gilead,daiichi sankyo
['axi-cel', ' ave ', 'lymphoma', 'axicel']
interesting results in a very small cohort of very difficult to treat patients. #ash22 
Heme/Onc; NHL/HL/CLL; economics in med. Adj Professor U South Carolina; Leadership/Strategy. Host: the #HealthcareUnfiltered Podcast. https://t.co/bsOxNVWWLZ